Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 892

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 892
---
 Net loss                                                                 | ​ | ​ | ​                               | $ |    -17,347 | ​ | ​ | ​ | ​    | $ |    -20,542 | ​ | ​ |
| Net loss per share attributable to common stockholders, basic anddiluted | ​ | ​ | ​                               | $ |      -0.91 | ​ | ​ | ​ | ​    | $ |      -1.07 | ​ | ​ |
| Weighted-average common shares outstanding, basic and diluted            | ​ | ​ | ​                               | ​ | 19,134,096 | ​ | ​ | ​ | ​    | ​ | 19,116,342 | ​ | ​ |
| Comprehensive loss:                                                      | ​ | ​ | ​                               | ​ |          ​ | ​ | ​ | ​ | ​    | ​ |          ​ | ​ | ​ |
| Net loss                                                                 | ​ | ​ | ​                               | $ |    -17,347 | ​ | ​ | ​ | ​    | $ |    -20,542 | ​ | ​ |
| Unrealized loss on short-term investments                                | ​ | ​ | ​                               | ​ |          — | ​ | ​ | ​ | ​    | ​ |        -24 | ​ | ​ |
| Comprehensive loss                                                       | ​ | ​ | ​                               | $ |    -17,347 | ​ | ​ | ​ | ​    | $ |    -20,566 | ​ | ​ |

The accompanying notes are an integral part of these financial statements. F-92

TABLE OF CONTENTS Tvardi Therapeutics, Inc. Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit
(Amounts in thousands, except share amounts)

| ​                                        
 ​                                        | ​ 
 ​ | ​ 
 ​ | RedeemableConvertiblePreferredStock 
 Shares                              |   |            |   | ​ | ​ | Amount |   |        |   | ​ 
 ​ | ​ 
 ​ | ​ 
 ​ | CommonStock 
 Shares      |   |            |   | ​ | ​ | Amount |   |    |   | ​ 
 ​ | ​ | AdditionalPaid-InCapital |   |     |   | ​ | ​ | AccumulatedDeficit |   |         |   | ​ | ​ | AccumulatedOtherComprehensiveLoss |   |     |   | ​ | ​ | TotalStockholders’Deficit |   |         |   | ​ |
|:-----------------------------------------|:--|: